Low-dose corticosteroids reduce relapses in neuromyelitis optica: A retrospective analysis

Multiple Sclerosis

Volumn 13, Issue 8, 2007, Pages 968-974

  Watanabe, S ^a   Misu, T ^a   Miyazawa, I ^a   Nakashima, I ^a   Shiga, Y ^a   Fujihara, Kazuo ^a   Itoyama, Y ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Autoantibody; Corticosteroids; Devic's disease; Neuromyelitis optica; Relapse; Therapy

Indexed keywords

CORTICOSTEROID; PREDNISOLONE;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE REDUCTION; DRUG EFFICACY; FEMALE; FOLLOW UP; HEMIPARESIS; HUMAN; LONG TERM CARE; LOW DRUG DOSE; MALE; MONOTHERAPY; MYELOOPTIC NEUROPATHY; RECURRENCE RISK; RELAPSE; RETROSPECTIVE STUDY; DRUG ADMINISTRATION; MIDDLE AGED; RECURRENT DISEASE;

ADRENAL CORTEX HORMONES; ADULT; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROMYELITIS OPTICA; RECURRENCE; RETROSPECTIVE STUDIES;

EID: 38449120510     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/1352458507077189     Document Type: Article

References (11)

1. Mandler RN, Davis LE, Jeffery DR, Kornfeld M. Devic's neuromyelitis optica: A clinicopathological study of 8 patients. Ann Neurol 1993; 34: 162-68.
2. O'Riordan JI, Gallagher HL, Thompson AJ, Howard RS, Kingsley DPE, Thompson EJ et al. Clinical, CSF, and MRI findings in Devic's neuromyelitis optica. J Neurol Neurosury Psychiatry 1996; 60: 382-87.
3. Wingerchuk DM, Hogancamp WF, O'Brien PC, Weinshenker BG. The clinical course of neuromyelitis optica (Devic's syndrome). Neurology 1999; 53: 1107-14.
4. Misu T, Fujihara K, Nakashima, I, Miyazawa I, Okita N, Takase S et al. Pure optic-spinal form of multiple sclerosis in Japan. Brain 2002; 125: 2460-68.
5. Lucchinetti CF, Mandler RN, McGavern D, Bruck W. Gleich G, Ransohoff RM et al. A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica. Brain 2002; 125: 1250-61.
6. Miyazawa I, Fujihara K, Itoyama Y. Neuromyelitis optica (Devic disease) and optic-spinal form multiple sclerosis. No To Shinkei 2001; 53: 901-10.
7. Lennon VA, Wingerchuk DM, Kryzer TJ, Pittock SJ, Lucchinetti CF, Fujihara K et al. A serum antibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 2004; 364: 2106-12.
8. Lennon VA, Kryzer TJ, Pittock SJ, Verkman AS, Hinson SR. IgG marker of optic-spinat multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med 2005; 202: 473-77.
9. Mandler RN, Ahmed W, Dencoff JE. Devic's neuromyelitis optica: a prospective study of seven patients treated with prednisone and azathioprine. Neurology 1998; 51: 1219-20.
10. Weinshenker BG, Wingerchuk DM, Vukusic S, Linho L, Pittock SJ, Lucchinetti CF et al. Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis. Ann Neurol 2006; 59: 566-69.
11. Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG. Revised diagnostic criteria for neuromyelitis optica. Neurology 2006; 66: 1485-89.